Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:15 / 17
页数:3
相关论文
共 50 条
  • [1] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma
    Sano, Dahlia
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Fayad, Luis
    Hagemeister, F. B.
    Lee, Hun Ju
    Samaniego, Felipe
    Wang, Michael
    Rodriguez, Maria Alma
    Iyer, Swaminathan P.
    Parmar, Simrit
    Steiner, Raphael
    Nair, Ranjit
    Adkins, Sherry
    Arafat, Sara
    Rao, Ahalya
    Vallejo, Liliana
    Hawkins, Misha
    Chen, Yiming
    Westin, Jason R.
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [2] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
    Neelapu, S. S.
    Locke, F. L.
    Bartlett, N. L.
    Lekakis, L. J.
    Miklos, D. B.
    Jacobson, C. A.
    Braunschweig, I.
    Oluwole, O. O.
    Siddiqi, T.
    Lin, Y.
    Timmerman, J. M.
    Stiff, P. J.
    Friedberg, J. W.
    Flinn, I. W.
    Goy, A.
    Hill, B. T.
    Smith, M. R.
    Deol, A.
    Farooq, U.
    McSweeney, P.
    Munoz, J.
    Avivi, I.
    Castro, J. E.
    Westin, J. R.
    Chavez, J. C.
    Ghobadi, A.
    Komanduri, K. V.
    Levy, R.
    Jacobsen, E. D.
    Witzig, T. E.
    Reagan, P.
    Bot, A.
    Rossi, J.
    Navale, L.
    Jiang, Y.
    Aycock, J.
    Elias, M.
    Chang, D.
    Wiezorek, J.
    Go, W. Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2531 - 2544
  • [5] Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma
    Halford, Zachery
    Anderson, Mary Kate
    Bennett, Lunawati L.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 390 - 405
  • [6] Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    Nastoupil, Loretta J.
    Jain, Michael D.
    Spiegel, Jay Y.
    Ghobadi, Armin
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew A.
    Lekakis, Lazaros J.
    Reagan, Patrick M.
    Oluwole, Olalekan O.
    McGuirk, Joseph P.
    Deol, Abhinav
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier
    Westin, Jason R.
    Chavez, Julio C.
    Cashen, Amanda F.
    Bennani, Nora N.
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Locke, Frederick L.
    BLOOD, 2018, 132
  • [7] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
    Shapiro, Lauren C.
    Mustafa, Jennat
    Lombardo, Amanda
    Khatun, Fariha
    Joseph, Felisha
    Gillick, Kailyn
    Naik, Anjali
    Elkind, Richard
    Abreu, Michelly
    Fehn, Karen
    de Castro, Alyssa
    Pradhan, Kith
    Binakaj, Donika
    Nelson, Randin
    Paroder, Monika
    Uehlinger, Joan
    Gritsman, Kira
    Alejandro Sica, R.
    Kornblum, Noah
    Shastri, Aditi
    Mantzaris, Ioannis
    Bachier-Rodriguez, Lizamarie
    Verma, Amit
    Braunschweig, Ira
    Goldfinger, Mendel
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1761 - 1763
  • [8] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
    Lauren C. Shapiro
    Jennat Mustafa
    Amanda Lombardo
    Fariha Khatun
    Felisha Joseph
    Kailyn Gillick
    Anjali Naik
    Richard Elkind
    Michelly Abreu
    Karen Fehn
    Alyssa de Castro
    Kith Pradhan
    Donika Binakaj
    Randin Nelson
    Monika Paroder
    Joan Uehlinger
    Kira Gritsman
    R. Alejandro Sica
    Noah Kornblum
    Aditi Shastri
    Ioannis Mantzaris
    Lizamarie Bachier-Rodriguez
    Amit Verma
    Ira Braunschweig
    Mendel Goldfinger
    Bone Marrow Transplantation, 2021, 56 : 1761 - 1763
  • [9] Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma
    Nath, Karthik
    Wudhikarn, Kitsada
    Alarcon Tomas, Ana
    Perales, Miguel-Angel
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (01) : 5 - 15
  • [10] Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
    Grana, Allison
    Gut, Natalia
    Williams, Kiersten
    Maakaron, Joseph
    Porter, Kyle
    William, Basem M.
    Vasu, Sumithira
    Penza, Sam
    Brammer, Jonathan E.
    Saad, Ayman
    Puto, Marcin
    Jaglowski, Samantha M.
    Roddy, Julianna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : 238 - 245